GeneLink Inc. accepted the resignation of Susan Hunt as Interim Chief Financial Officer of the company effective as of February 8, 2013. Ms. Hunt will continue to provide consulting services through the filing of Form 10-K for the year ended December 31, 2012. Bernard L. Kasten, Jr., M.D., the CEO and President will assume the duties of interim CFO until such time as the company hires a replacement CFO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | +900.00% |
2015 | GeneLink Inc. Emerged from Bankruptcy | CI |
2015 | Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+900.00% | 2.65K | |
-24.88% | 7.74B | |
+70.87% | 4.39B | |
+2.44% | 2.61B | |
-7.01% | 2.53B | |
-44.62% | 2.22B | |
-12.67% | 1.8B | |
-19.62% | 1.54B | |
+18.85% | 1.23B | |
-43.60% | 1.15B |
- Stock Market
- Equities
- GNLKQ Stock
- News GeneLink, Inc.
- GeneLink Inc. Announces Executive Changes